Literature DB >> 20856216

IAPP boosts islet macrophage IL-1 in type 2 diabetes.

Thomas Mandrup-Poulsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20856216     DOI： 10.1038/ni1010-881

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  11 in total

Review 1.  Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors:  Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 2.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

3.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

Authors:  P Westermark; C Wernstedt; E Wilander; D W Hayden; T D O'Brien; K H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

4.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

5.  The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.

Authors:  Allison B Goldfine; Vivian Fonseca; Kathleen A Jablonski; Laura Pyle; Myrlene A Staten; Steven E Shoelson
Journal:  Ann Intern Med       Date:  2010-03-16       Impact factor: 25.391

6.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

7.  Autoinflammatory disease reloaded: a clinical perspective.

Authors:  Daniel L Kastner; Ivona Aksentijevich; Raphaela Goldbach-Mansky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

8.  Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.

Authors:  Kathrin Maedler; Joachim Størling; Jeppe Sturis; Richard A Zuellig; Giatgen A Spinas; Per O G Arkhammar; Thomas Mandrup-Poulsen; Marc Y Donath
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

Review 9.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 10.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461
View more
  18 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

2.  The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.

Authors:  Chun Zeng; Xiaoyun Shi; Baojun Zhang; He Liu; Lianjun Zhang; Wenjun Ding; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2011-10-01       Impact factor: 4.599

3.  IAPP stokes the pancreatic fire.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

Review 4.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 5.  Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes.

Authors:  Thomas Mandrup-Poulsen
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 6.  Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients.

Authors:  Yachana Kataria; Christina Ellervik; Thomas Mandrup-Poulsen
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

Review 7.  Immunometabolism in 2017: Metabolism and the inflammasome in health and ageing.

Authors:  Thomas Mandrup-Poulsen
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

8.  Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization.

Authors:  Amin Ardestani; Nadine S Sauter; Federico Paroni; Gitanjali Dharmadhikari; Jae-Hyoung Cho; Roberto Lupi; Piero Marchetti; José Oberholzer; Julie Kerr Conte; Kathrin Maedler
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

9.  The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.

Authors:  Stanley S Schwartz; Solomon Epstein; Barbara E Corkey; Struan F A Grant; James R Gavin; Richard B Aguilar
Journal:  Diabetes Care       Date:  2016-02       Impact factor: 19.112

10.  Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity.

Authors:  Hua-Ping Li; Xuan Chen; Ming-Qing Li
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.